FLA - External validation

m.kotrova@med2.uni-kiel.de

1 Responders, Platforms and Chip Types

1.1 Number of Patients Analyzed

2 Positive controls

2.1 Peak Length Differences between Positive Controls

2.1.1 All Platforms and Chip Types

2.1.1.1 By Dilution Difference

TUR submitted patients with different combinations of 1E-0X, 3E-0X abnd 5E-0X dilutions, this is where all the differences other than full or half log come from.

2.1.1.2 By Chip Position

2.1.2 By Platform / Chip Type

2.1.2.1 By Dilution Difference

2.1.2.2 By Chip Position

2.1.3 By Lab

2.1.3.1 By Dilution Difference

2.1.3.2 By Chip Position

3 Follow-Up Samples

3.1 Peak Length Differences Between Positive Control and Questionable Sample

3.1.1 All Platforms and Chip Types

3.1.2 By Platform and Chip Type

3.1.3 By Lab